Report Description

India clindamycin phosphate market is expected to grow at a steady rate during the forecast period. The India clindamycin phosphate market is driven by the growing awareness pertaining to personal grooming among the population, especially youth. Additionally, widespread use of clindamycin in treatment of acne is further expected to fuel market growth through FY2026. Clindamycin phosphate helps in reducing acne lesions. This in turn is expected to positively influence the market growth through FY2026. 

The India clindamycin phosphate market is segmented based on product type, source, form, gender, distribution channel, application, company and region. Based on product type, the market can be split into prescription and OTC. The prescription drug segment is expected to dominate the market since most of the dermatologists prescribe this drug for the treatment of acne vulgaris. Based on gender, the market can be bifurcated into male and female. The female segment is expected to dominate the market owing to the growing prevalence of problems like PCOS, hormonal imbalances, among others which lead to emergence of acne.

The major players operating in the India clindamycin phosphate market are Mylan Pharmaceuticals Private Limited, Midas Care Pharmaceuticals Pvt. Ltd., Taro Pharmaceuticals India Private Limited, Alvogen Pharma India Pvt. Ltd., Fresenius Kabi India Pvt. Ltd., Akorn India Pvt. Ltd., Cadila Pharmaceuticals, Perrigo India Pvt. Ltd., Sun Pharmaceuticals Industries Ltd, Alvogen Pharma India Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, pharma licensing, research collaborations and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India clindamycin phosphate market from FY2016 to FY2019.
  • To estimate and forecast the market size of India clindamycin phosphate market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India clindamycin phosphate market based on product type, source, form, gender, distribution channel, application, company and regional distribution.
  • To identify dominant region or segment in the India clindamycin phosphate market.
  • To identify drivers and challenges for India clindamycin phosphate market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India clindamycin phosphate market.
  • To identify and analyze the profile of leading players operating in India clindamycin phosphate market.
  • To identify key sustainable strategies adopted by market players in India clindamycin phosphate market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India clindamycin phosphate market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Clindamycin Phosphate manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to clindamycin phosphate

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India clindamycin phosphate market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Clindamycin Phosphate Market, By Product Type:
    • Prescription
    • OTC
  • India Clindamycin Phosphate Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Clindamycin Phosphate Market, By Form:
    • Gel
    • Topical Solution
    • Foam
    • Injection
    • Others
  • India Clindamycin Phosphate Market, By Gender:
    • Male
    • Female
  • India Clindamycin Phosphate Market, By Distribution Channel:
    • Online
    • Offline
  • India Clindamycin Phosphate Market, By Application:
    • Acne Vulgaris
    • Genito-Urinary Infections
    • Pseudomembranous Colitis
    • Others
  • India Clindamycin Phosphate Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India clindamycin phosphate market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Clindamycin Phosphate market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Clindamycin Phosphate Market

4.    Executive Summary

5.    Manufacturing Clindamycin Phosphate

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Clindamycin Phosphate

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Clindamycin Phosphate Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product Type (Prescription v/s OTC)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Form (Gel, Topical Solution, Foam, Injection, Others)

7.2.4.     By Gender (Men v/s Women)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Acne Vulgaris, Genito-Urinary Infections, Pseudomembranous Colitis, Others)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Mylan Pharmaceuticals Private Limited      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Midas Care Pharmaceuticals Pvt. Ltd.

14.1.3.  Taro Pharmaceuticals India Private Limited

14.1.4.  Alvogen Pharma India Pvt. Ltd.

14.1.5.  Fresenius Kabi India Pvt. Ltd.

14.1.6.  Akorn India Pvt. Ltd.

14.1.7.  Cadila Pharmaceuticals

14.1.8.  Perrigo India Pvt. Ltd.

14.1.9.  Sun Pharmaceuticals Industries Ltd.

14.1.10.                Alvogen Pharma India Pvt. Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions